WHO: Hepatitis Death Toll Rising

Hepatitis-related mortality is on the rise, despite the existence of an efficient vaccine for hepatitis B and a cure for hepatitis C, according to the World Health Organization hepatitis report 2017 published today. One of the issues is that a majority of people are unaware of their condition due to limited access to affordable [...]

By |2017-09-07T19:07:39+05:30April 22nd, 2017|IP Basics, Patent|0 Comments

Novartis last shot to protect its anti cancer drug “Glivec”

In 2006 Novartis had sued Indian Government for not granting patent to its anti cancer drug Imatinib selling under brand name ” Glivec“. It also challenged the constitutional validity of section 3 d of Indian Patent Act 1970 which says new forms including esters, ethers, acids or other derivatives of known substance are not [...]

By |2017-09-07T13:04:29+05:30March 5th, 2012|International, IP Basics|0 Comments
Go to Top